Mortality is higher for Black patients receiving neoadjuvant chemo for breast cancer: Study

For patients with early-stage breast cancer treated with neoadjuvant chemotherapy (NACT), Blacks have higher mortality risk than Whites, according to a study published online Nov. 22 in JAMA Network Open.

Leave A Comment

Your email address will not be published. Required fields are marked *